Check out our most popular compounded medications! Get Started
Morphine Sulfate 65 mg Slow Release Capsules are formulated with Methocel E4M, a controlled-release polymer. This design allows for the gradual release of the active ingredient over an extended period, providing sustained therapeutic effects. This formulation is used to treat various types of pain including chronic, cancer, postoperative, neuropathic, and arthritis pain. The slow release mechanism reduces dosing frequency and improves patient compliance for medications requiring a controlled and prolonged release profile.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Morphine Sulfate 65 mg Slow Release Capsules are a potent, long-acting opioid analgesic designed to manage moderate to severe pain. This formulation is specifically engineered to provide a steady, consistent release of the active ingredient, Morphine Sulfate, over an extended period of time.
The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This polymer is designed to gradually release the encapsulated medication over time, offering sustained therapeutic effects. This reduces the need for frequent dosing and improves patient compliance, particularly for medications that require a controlled and prolonged release profile.
However, this formulation is not recommended for patients with acute pain, as it may not provide immediate or adequate pain relief. It is also important for patients to be aware that Morphine Sulfate 65 mg Slow Release Capsules may cause side effects such as drowsiness, dizziness, and confusion. As such, patients should refrain from driving or operating machinery while taking this medication.
Patients should also be aware of the potential for dependency with this medication. It is habit-forming and should not be taken for longer than prescribed. It is crucial to follow the prescribed dosage and duration to avoid potential addiction or dependency.
For healthcare providers, it is important to note that Morphine Sulfate 65 mg Slow Release Capsules may cause respiratory depression. Therefore, it should be used with caution in patients with respiratory conditions. As with patients, healthcare providers should also be aware of the potential for dependency with this medication and should prescribe it for the shortest duration possible to manage the patient's pain effectively.
If you have any questions or concerns about Morphine Sulfate 65 mg Slow Release Capsules, please do not hesitate to contact us at Bayview Pharmacy. We are here to provide you with the information and support you need to ensure safe and appropriate use of this medication.
Morphine Sulfate 65 mg Slow Release Capsules are a specialized formulation designed for the management of moderate to severe pain. These capsules are uniquely formulated with Methocel E4M, a type of controlled-release polymer. This innovative technology allows for the gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects. This slow-release mechanism not only enhances the efficacy of the medication but also reduces the frequency of dosing, thereby improving patient compliance, particularly for medications requiring a controlled and prolonged release profile.
It is crucial to note that this formulation is contraindicated in patients with known hypersensitivity to morphine or other opioids, as well as in patients with significant respiratory depression. Close monitoring is required for signs of respiratory depression, sedation, and hypotension. Additionally, vigilance is necessary for signs of opioid abuse or misuse, including drug-seeking behavior.
Patients are strongly advised to abstain from alcohol and other CNS depressants while on this medication. Activities requiring mental alertness, such as operating machinery or driving, should be avoided until the patient is fully aware of how this medication affects them. In the event of any signs of an allergic reaction, such as rash, hives, or difficulty breathing, patients should seek immediate medical attention.
Morphine Sulfate 65 mg Slow Release Capsules are a potent, extended-release opioid medication designed to manage moderate to severe pain. The capsules are formulated with Methocel E4M, a type of controlled-release polymer. This innovative formulation allows for a gradual release of the encapsulated medication over an extended period, providing sustained therapeutic effects and more consistent pain relief.
The slow-release mechanism of these capsules reduces the dosing frequency, typically requiring only a once-daily oral administration, preferably with food. This feature can significantly improve patient compliance, especially for those on long-term medication regimens. However, it is crucial to adhere strictly to the prescribed dosage and frequency set by your healthcare provider. Overdosing or frequent dosing can lead to adverse effects or dependency.
Morphine Sulfate 65 mg Slow Release Capsules are versatile in their application, providing relief for various disease states. Additionally, they can be used to alleviate pain associated with end-stage renal disease, rheumatoid arthritis, and other chronic conditions.
While effective, Morphine Sulfate 65 mg Slow Release Capsules can cause side effects such as nausea, constipation, dizziness, drowsiness, and confusion. It is essential to communicate with your healthcare provider about any side effects you experience while taking this medication. They can provide guidance and possible solutions to manage these side effects effectively.
If you have any questions or concerns about Morphine Sulfate 65 mg Slow Release Capsules, please do not hesitate to reach out to your healthcare provider or pharmacist. They can provide comprehensive information about this medication, its mechanism of action, and how it can help manage your pain effectively.
Morphine Sulfate 65 mg Slow Release Capsules are a potent analgesic formulation designed to provide sustained relief from various types of pain, including musculoskeletal pain, fibromyalgia, and headaches. The slow-release mechanism, facilitated by Methocel E4M, a controlled-release polymer, ensures a gradual release of the active ingredient over an extended period, thereby reducing the dosing frequency and enhancing patient compliance.
They can also be used to alleviate the discomfort of opioid-induced constipation and to mitigate the severity of withdrawal symptoms in patients with opioid dependence.
However, caution should be exercised when administering Morphine Sulfate 65 mg Slow Release Capsules to patients with renal or hepatic impairment, as well as those with a history of substance abuse. Regular monitoring for signs of respiratory depression, sedation, and constipation is recommended to ensure patient safety and efficacy of the treatment.
It is important to consult with a healthcare professional for any questions or concerns regarding the use of Morphine Sulfate 65 mg Slow Release Capsules for these or other indications.
Morphine Sulfate 65 mg Slow Release Capsules is a medication formulated with Methocel E4M, a type of controlled-release polymer. This formulation is designed to release the encapsulated medication gradually over an extended period of time, offering sustained therapeutic effects.
The controlled-release polymer, Methocel E4M, is designed to gradually release the active ingredient over an extended period of time. This offers sustained therapeutic effects, reduces the frequency of dosing, and improves patient compliance for medications requiring a controlled and prolonged release profile.
Due to the controlled-release nature of this medication, the dosing frequency is typically reduced. However, the exact frequency will depend on your doctor's prescription and your specific medical condition.
Slow release capsules offer several benefits including sustained therapeutic effects, reduced dosing frequency, and improved patient compliance. This is particularly beneficial for medications requiring a controlled and prolonged release profile.
No, breaking or chewing the capsules can interfere with the controlled-release mechanism and may lead to rapid release of the drug, which can be dangerous.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Do not double the dose to catch up.
Side effects may include nausea, vomiting, constipation, lightheadedness, dizziness, or drowsiness. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
No, alcohol can increase the risk of serious side effects, including severe drowsiness and respiratory depression. Always consult your healthcare provider for advice on medication interactions.
This medication should be used during pregnancy only if clearly needed. It may harm an unborn baby. Discuss the risks and benefits with your doctor.
Store at room temperature away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take 1 capsule by mouth
